PRNewsWire
21 May 2026, 19:45 UTC · 2h ago
Source · https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-sanara-medtech-inc---smti-302779477.html
Read source
Story key points
3 claims · impact-rated
Pomerantz LLP is investigating Sanara MedTech (SMTI) for potential securities fraud or unlawful business practices. — Legal investigations into securities fraud create significant uncertainty and risk of future litigation costs or regulatory penalties.
-0.60Sanara MedTech discontinued operations of its Tissue Health Plus (THP) program. — The cessation of a specific business program represents a failure in a strategic initiative and a loss of potential revenue streams.
-0.40Sanara reported a $31.2 million net loss from discontinued operations, including a $26.5 million noncash asset impairment charge. — Large impairment charges negatively affect the balance sheet and signal that previous investments in the THP program were overvalued.
-0.30Impact vectors
Search tags
3 dimensions · 9 clusters
Market reaction
0 bid · 0 offered
No stock impact ranking available yet.
No stock impact ranking available yet.
Ticker attribution
Model heads
The company is being investigated by a law firm for claims on behalf of investors.
The company is being investigated by a law firm for claims on behalf of investors.
The company is the subject of a securities fraud investigation following a massive net loss and a significant stock price drop.
No ticker relationship head found.
